Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 19 entities : Gilead sciences, inc. save search
European Medicines Agency Validates Gilead’s Marketing Authorization Application for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options
Published: 2021-08-19 (Crawled : 23:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.49%
H: 1.01%
C: 0.08%
treatment europe therapy hiv authorized xin
Global Antifungal Drug Market Report 2021: Presence of Counterfeit Drugs and Resistance Toward Antifungal Drugs a Major Market Challenge - Forecast to 2026
Published: 2021-08-19 (Crawled : 22:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.56%
H: 0.87%
C: 0.7%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
drug
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
NOV 4 | $18.75 1.35% -6.67% 3.2M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.